Published • loading... • Updated
Cleveland Clinic and IBM Develop Quantum Machine Learning Model for Cancer Neoantigen Prediction
Summary by Quantum Computing Report
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cleveland Clinic and IBM Develop Quantum Machine Learning Model for Cancer Neoantigen Prediction
Researchers from the Cleveland Clinic and IBM Research have developed a quantum machine learning framework to predict which tumor gene mutations generate immunogenic neoantigens—abnormal cell-surface proteins that trigger a therapeutic T-cell immune response. Published in Science Advances under the title "Quantum convolutional HLA immunogenic peptide prediction (Q-CHIPP): Next-generation neoantigen prediction with quantum neural network," the [.…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
